| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.150 | None | 1.000 | 1 | 1 | 2010 | 2019 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
disease | 0.200 | None | 0.922 | 1 | 1 | 1994 | 2020 | ||||||||
|
synuclein alpha | 0.427 | 0.885 | 0.88 |
|
disease | 0.700 | None | 0.983 | 16 | 7 | 1997 | 2020 | ||||||||
|
microtubule associated protein tau | 0.446 | 0.923 | 6.0E-03 |
|
disease | 0.500 | None | 0.972 | 3 | 2 | 1999 | 2019 | ||||||||
|
cathepsin B | 0.457 | 0.846 | 5.9E-11 |
|
disease | 0.140 | None | 1.000 | 1 | 1 | 2016 | 2020 | ||||||||
|
cytochrome P450 family 17 subfamily A member 1 | 0.462 | 0.769 | 2.6E-04 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2009 | 2009 | ||||||||
|
glucosylceramidase beta | 0.500 | 0.808 | 1.4E-06 |
|
disease | 0.500 | None | 0.989 | 1 | 1 | 2004 | 2020 | ||||||||
|
leucine rich repeat kinase 2 | 0.510 | 0.808 | 2.6E-30 |
|
disease | 0.500 | None | 0.983 | 6 | 5 | 2002 | 2020 | ||||||||
|
GTP cyclohydrolase 1 | 0.511 | 0.846 | 0.90 |
|
disease | 0.200 | None | 1.000 | 3 | 1 | 1996 | 2019 | ||||||||
|
sodium voltage-gated channel alpha subunit 2 | 0.518 | 0.731 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
sterol regulatory element binding transcription factor 1 | 0.518 | 0.808 | 1.5E-02 |
|
disease | 0.140 | None | 0.750 | 1 | 1 | 2011 | 2019 | ||||||||
|
Wnt family member 3 | 0.536 | 0.808 | 0.88 |
|
disease | 0.100 | None | 1.000 | 3 | 3 | 2011 | 2014 | ||||||||
|
peptidylglycine alpha-amidating monooxygenase | 0.542 | 0.692 | 6.9E-06 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2016 | 2017 | ||||||||
|
tropomyosin 1 | 0.560 | 0.615 | 1.0E-03 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
glycoprotein nmb | 0.566 | 0.692 | 2.9E-27 |
|
disease | 0.160 | None | 1.000 | 2 | 1 | 2011 | 2019 | ||||||||
|
collagen type V alpha 2 chain | 0.568 | 0.731 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
LINC02210-CRHR1 readthrough | 0.570 | 0.692 |
|
disease | 0.100 | None | 1.000 | 3 | 3 | 2009 | 2016 | |||||||||
|
major histocompatibility complex, class II, DR alpha | 0.581 | 0.769 | 0.52 |
|
disease | 0.480 | None | 1.000 | 2 | 1 | 2010 | 2015 | ||||||||
|
mitogen-activated protein kinase kinase kinase kinase 4 | 0.588 | 0.692 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
KAT8 regulatory NSL complex subunit 1 | 0.592 | 0.731 | 1.00 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2008 | 2014 | ||||||||
|
carbonic anhydrase 8 | 0.595 | 0.654 | 8.3E-03 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
contactin 1 | 0.599 | 0.577 | 0.15 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | ||||||||
|
collagen type XIII alpha 1 chain | 0.608 | 0.654 | 3.7E-14 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||||||
|
BMP/retinoic acid inducible neural specific 1 | 0.615 | 0.615 | 0.99 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2010 | ||||||||
|
NADH:ubiquinone oxidoreductase complex assembly factor 2 | 0.641 | 0.577 | 2.1E-06 |
|
disease | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2017 |